This can explain the seemingly low expression levels of HLADR and CD40 on primary breast cancer CD169+ TAMs in the proteome analysis (Figure 3A) since B cells express high levels of HLADR and CD40 in general. Here, SIGLEC1 is linked to breast carcinoma.